TY - Jour A2 - Aloisi，Anna Maria Au - Kim，Minsoo Au - Bak，九原Au - Kim，Sejin Au - Son，Hee-Jeong Au - Kang，Seong-Sik Au - Hue，Jin Au - Hwang，Byeongmun Au -Lee，Seung Koo Py - 2020 da - 2020/12/07 - 腰硬膜外类固醇注射对糖尿病糖尿病患者骨质疏松骨折和骨密度的影响Mellitus sp - 1538029 Vl - 2020 ab - 骨质疏松症和糖尿病的发病率（DM）已知随老化增加。DM与骨质疏松骨折和骨质矿物代谢降低有关。然而，没有研究DM对硬膜外类固醇注射（IERS）后骨密度（BMD）和骨质疏松骨折变化的影响。本研究旨在分析ESI和BMD在没有DM的老年妇女之间的关系。回顾性地分析了接受ESI的老年妇女的病程。所有患者在接受腰椎之前和之后进行射线照相和BMD评估。根据DM的存在，共172名患者分为两组。BMD监测的持续时间分别为非DM和DM组的16.1和16.8个月。 The mean total number of ESIs was 3.4 and 3.2, and the mean cumulative administered dose of glucocorticoids (dexamethasone) was 17 and 16 mg in the non-DM and DM groups, respectively. There were no significant differences between baseline and posttreatment BMD in the lumbar spine, total femur, and femoral neck region in either group. The incidence of osteoporotic fractures at the hip joint and thoracolumbar spine was not significantly different in both groups. ESIs could be used without concerns regarding osteoporosis and fractures in elderly women with DM if low doses of glucocorticoids are used. SN - 1203-6765 UR - https://doi.org/10.1155/2020/1538029 DO - 10.1155/2020/1538029 JF - Pain Research and Management PB - Hindawi KW - ER -